Modality Leadership
Established experience in Cell & Gene (25+ years), mRNA (5+ years), and Microbial (30+ years)
450+ Process Development Projects:
Proven track record transforming cutting-edge science into scalable, advanced manufacturing – backed by modern, purpose-built facilities
16 Pre-Licensing Inspections (PLIs) Passed:
Regulatory confidence at every stage, with deep expertise in bringing products to market
Specialized Modalities
Contract Development Manufacturing Services
Células y genes
Established expertise accelerating your path to IND and beyond to commercialize and deliver cell and gene therapies
Más información
mRNA/LNP
Benefit from our end-to-end services for manufacturing and development of mRNA/LNP products
Más información
Microbios
Scale and futureproof your next-gen biologic with Lonza’s advanced microbial fermentation services
Más información

Products and Technologies

Productos biocientíficos
Our products and services range from cell culture and discovery technologies for research to quality control tests and software for biomanufacturing
Más información
Plataforma Cocoon®
The Cocoon® Platform streamlines cell therapy manufacturing resulting in greater efficiency and reliability. Automated, closed, and flexible, this...
Más información
Perspectivas relacionadas
Webinar (on-demand)
Producing Engineered Extracellular Vesicles with a Platform Approach
In this webinar, we'll discuss materials and methods to enable the expression of biomolecules on...
Peer-reviewed publication
Three-Dimensional Linkage Analysis With Digital PCR for Genome Integrity and Identity of Recombinant...
Abstract: Recombinant adeno-associated virus (rAAV) has emerged as the vector of choice for in vivo...
Article
Women In Science Spotlight
Women In Science Spotlight featuring Inbar Friedrich Ben-Nun, Director of R&D, Lonza Cell & Gene...
Video
CAR-T Cells on the Fast Lane: From T-cell Selection to CAR-T Cell Drug Product in Just 3 Days
In this presentation, we explore the rapid growth of the CAR T market, driven by oncology...
Article
An interview with Lisa Prendergast for Next Generation Gene Therapy Vectors Conference
Dr. Lisa Prendergast leads innovation for Lonza's Licensing Business Unit, supporting the growth of...
Houston, TX facility,Woman working in lab,PD scientist in lab,CGT Houston Process Development
Technical/Service brief
Translating Exosome Candidates into Approved Therapies with engEx® Platform Technologies
Exosomes represent one type of extracellular vesicle (EV) generated by all eukaryotic cells....
Cocoon device
Technical/Service brief
Cocoon® CAR-T™: Manufacturing Cell Therapies in the Lonza Cocoon® Platform - 9-day Process
Performance data of the 9-day process for functionally-closed and automated manufacture of...
Webinar (on-demand)
Enhancing CAR-T Therapy Development - Harnessing Cell Selection Flexibility
Abstract: During this webinar, our experts will explore recent developments that highlight the...
Technical/Service brief
GMP Tissue Sourcing
A complex process, prone to misconceptions and pitfalls, to find the “right human tissue” that will...
Visitar el Centro de conocimientos
Últimas noticias
11 de mar. de 2025
Aviso a los medios
Exogenus Therapeutics Chooses Lonza to Develop a GMP-Compliant Process to Manufacture Exo-101, its...
Ver artículo
26 de sep. de 2024
Aviso a los medios
Lonza Walkersville Commences Expansion of Endotoxin Assay Production Facility
Ver artículo
24 de sep. de 2024
Comunicado de prensa
Lonza and Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY® (exagamglogene...
Ver artículo
13 Aug 2024
Aviso a los medios
Champalimaud Foundation Adopts Lonza’s MODA-ES® Platform to Streamline Cell Therapy Manufacturing
Ver artículo
9 de abr. de 2024
Aviso a los medios
NeuroSense Collaborates with Lonza to Identify Exosome-based Biomarkers, in order to Advance...
Ver artículo
24 de oct. de 2023
Aviso a los medios
Lonza’s Rapid PyroCell® Monocyte Activation Test Systems Make Rabbit-Free Pyrogen Testing Faster,...
Ver artículo
7 de sep. de 2023
Aviso a los medios
Lonza Upgrades MODA-ES® Module for Enhanced Electronic Batch Record Execution
Ver artículo
30 Aug 2023
Aviso a los medios
Lonza and Vertex Celebrate Groundbreaking of Cell Therapy Manufacturing Facility in Portsmouth (US)
Ver artículo
8 Aug 2023
Aviso a los medios
Lonza Launches Nebula® Absorbance Reader for Streamlined Endotoxin and Pyrogen Testing
Ver artículo
17 Jul 2023
Comunicado de prensa
Lonza Launches TheraPRO® CHO Media System to Improve Productivity and Quality in Therapeutic Protein...
Ver artículo
17 Jul 2023
Aviso a los medios
Lonza Launches TheraPRO® CHO Media System to Improve Productivity and Quality in Therapeutic Protein...
Ver artículo
26 de jun. de 2023
Comunicado de prensa
Vertex and Lonza to Build Dedicated Manufacturing Facility for Type 1 Diabetes (T1D) Cell Therapies
Ver artículo
16 de may. de 2023
Aviso a los medios
Lonza Launches TheraPEAK® T-VIVO® Cell Culture Medium to Accelerate Cell Therapy Development
Ver artículo
25 de oct. de 2022
Aviso a los medios
Lonza Expands Global Process Development Team and Laboratory Spaces for Cell and Gene Development
Ver artículo
12 de sep. de 2022
Comunicado de prensa
Lonza Appoints Daniel Palmacci as President of the Cell & Gene Division
Ver artículo
Ver todos los artículos